1
|
Mariniello DF, Aronne L, Vitale M, Schiattarella A, Pagliaro R, Komici K. Current challenges and perspectives in lung cancer care during COVID-19 waves. Curr Opin Pulm Med 2023; 29:239-247. [PMID: 37132294 PMCID: PMC10241323 DOI: 10.1097/mcp.0000000000000967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
PURPOSE OF REVIEW In the era of the SARS-Cov2 pandemic, the multidisciplinary care of patients with lung cancer is the main challenge for clinicians. The depiction of complex networking between SARS-CoV2 and cancer cells is crucial to understanding the downstream signalling pathways leading to more severe clinical behaviour of COVID-19 among lung cancer patients. RECENT FINDINGS The immunosuppressive status caused by both blunted immune response and active anticancer treatments (e.g. radiotherapy, chemotherapy) affects also the response to vaccines. Furthermore, the COVID-19 pandemic has significantly influenced early detection, therapeutic management, and clinical research for patients with lung cancer. SUMMARY SARS-CoV-2 infection does undoubtedly represent a challenge for care of patients with lung cancer. Since symptoms of infection may overlap with underlying condition, diagnosis must be reached and treatment should start as soon as possible. Although any cancer treatment should be procrastinated as long as infection is not cured, every choice must be pondered on individual basis, according to clinical conditions. Underdiagnosis should be avoided, and both surgical and medical treatment must be tailored to each patient. Therapeutic scenario standardization represents a major challenge for clinicians and researchers.
Collapse
Affiliation(s)
| | - Luigi Aronne
- Department of Translational Medical Science, University of Campania Luigi Vanvitelli
| | - Maria Vitale
- CEINGE, Biotecnologie Avanzate
- Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, Naples
| | - Angela Schiattarella
- Department of Translational Medical Science, University of Campania Luigi Vanvitelli
| | - Raffaella Pagliaro
- Department of Translational Medical Science, University of Campania Luigi Vanvitelli
| | - Klara Komici
- Department of Medicine and Health Sciences University of Molise, Campobasso, Italy
| |
Collapse
|
2
|
Ensergueix G, Karras A. [Ifosphamide nephrotoxicity]. Nephrol Ther 2018; 14 Suppl 1:S125-S131. [PMID: 29606257 DOI: 10.1016/j.nephro.2018.02.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2018] [Accepted: 02/01/2018] [Indexed: 02/01/2023]
Abstract
Ifosfamide is a cytotoxic drug usually used in malignant sarcomas. The nephrotoxicity of this agent has been described essentially among children, revealed by renal failure and proximal tubulopathy. We recently conducted a retrospective multicentre study, describing 34 adult patients admitted for ifosfamide nephrotoxicity. More than 80% of them presented with renal failure, diagnosed up to 48 months after ifosfamide administration. A Fanconi syndrome with hypophosphoremia, hypokaliemia, glucosuria and low-molecular weight proteinuria, was present in two third of all cases. Median estimated glomerular filtration rate was 31mL/min 1 month and 38mL/min 3 months after ifosfamide infusion, versus 67mL/min at baseline. Renal biopsy, performed in 14 of these patients, showed acute tubular necrosis with vacuolization of proximal tubular epithelial cells with marked nuclear modifications, whereas electron microscopy revealed major changes of mitochondrial structure inside those cells, suggesting a tenofovir-like mechanism of nephrotoxicity. After a median follow-up of 31 months, ten patients out of 34 reached stage 5 chronic kidney disease, requiring dialysis in five cases. Poor renal prognosis was associated with concomitant cisplatin use (P=0.02) and with older age at presentation (P=0.04). In conclusion, ifosfamide nephrotoxicity is often severe and irreversible, leading to proximal tubulopathy and sometimes-severe chronic kidney failure, that can be immediate or delayed, sometimes diagnosed months after chemotherapy completion.
Collapse
Affiliation(s)
- Gaël Ensergueix
- Service de néphrologie, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France.
| | - Alexandre Karras
- Service de néphrologie, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France; Faculté de médecine, université Paris-Descartes, 20, rue Leblanc, 75015 Paris, France.
| |
Collapse
|
3
|
Bianco A, Malapelle U, Rocco D, Perrotta F, Mazzarella G. Targeting immune checkpoints in non small cell lung cancer. Curr Opin Pharmacol 2018. [DOI: 10.1016/j.coph.2018.02.006] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
4
|
Mazzella A, Santagata M, Cecere A, La Mart E, Fiorelli A, Tartaro G, Tafuri D, Testa D, Grella E, Perrotta F, Bianco A, Mazzarella G, Santini M. Descending necrotizing mediastinitis in the elderly patients. Open Med (Wars) 2016; 11:449-460. [PMID: 28352835 PMCID: PMC5329867 DOI: 10.1515/med-2016-0080] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2016] [Accepted: 08/19/2016] [Indexed: 12/20/2022] Open
Abstract
Descending Necrotizing Mediastinitis (DNM) is a polymicrobic, dangerous and often fatal process, arising from head or neck infections and spreading along the deep fascial cervical planes, descending into the mediastinum. It can rapidly progress to sepsis and can frequently lead to death. It has a high mortality rate, up to 40% in the different series, as described in the literature. Surgical and therapeutic management has been discussed for long time especially in an elderly patient population. The literature has been reviewed in order to evaluate different pathogenesis and evolution and to recognise a correct therapeutic management.
Collapse
Affiliation(s)
| | - Mario Santagata
- Maxillo-Facial Surgery Unit, Second University of Naples, Italy
| | - Atirge Cecere
- Maxillo-Facial Surgery Unit, Second University of Naples, Italy
| | - Ettore La Mart
- Maxillo-Facial Surgery Unit, Second University of Naples, Italy
| | | | | | - Domenico Tafuri
- Department of Sport Sciences and Wellness, University of Naples "Parthenope", Naples, Italy
| | - Domenico Testa
- Department of Anesthesiologic, Surgical and Emergency Sciences, Otolaryngology, Head and Neck Surgery Unit, Second University of Naples, Naples, Italy
| | - Edoardo Grella
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Italy
| | - Fabio Perrotta
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Italy
| | - Andrea Bianco
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Piazza Miraglia, 2, 80138 Naples, Italy
| | - Gennaro Mazzarella
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Italy
| | - Mario Santini
- Thoracic Surgery Unit, Second University of Naples, Italy
| |
Collapse
|
5
|
Salvi R, Meoli I, Cennamo A, Perrotta F, Saverio Cerqua F, Montesano R, Curcio C, Lassandro F, Stefanelli F, Grella E, Tafuri D, Mazzarella G, Bianco A. Preoperative high-intensity training in frail old patients undergoing pulmonary resection for NSCLC. Open Med (Wars) 2016; 11:443-448. [PMID: 28352834 PMCID: PMC5329866 DOI: 10.1515/med-2016-0079] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2016] [Accepted: 09/06/2016] [Indexed: 01/11/2023] Open
Abstract
Thoracic surgery remains the better therapeutic option for non-small cell lung cancer patients that are diagnosed in early stage disease. Preoperative lung function assessment includes respiratory function tests (RFT) and cardio-pulmonary exercise testing (CPET). Vo2 peak, FEV1 and DLCO as well as recognition of performance status, presence of co-morbidities, frailty indexes, and age predict the potential impact of surgical resection on patient health status and survival risk. In this study we have retrospectively assessed the benefit of a high-intensity preoperative pulmonary rehabilitation program (PRP) in 14 patients with underlying lung function impairment prior to surgery. Amongst these, three patients candidate to surgical resection exhibited severe functional impairment associated with high score of frailty according CHS and SOF index, resulting in a substantial mortality risk. Our observations indicate that PRP appear to reduce the mortality and morbidity risk in frail patients with concurrent lung function impairment undergoing thoracic surgery. PRP produced improvement of VO2 peak degree and pulmonary function resulting in reduced postoperative complications in high-risk patients from our cases. Our results indicate that a preoperative training program may improve postoperative clinical outcomes in fraillung cancer patients with impaired lung function prior to surgical resection.
Collapse
Affiliation(s)
- Rosario Salvi
- Unit of Thoracic Surgery, A.O. Dei Colli - Monaldi Hospital, Naples, Italy
| | - Ilernando Meoli
- Unit of Pneumology, A.O. Dei Colli - Monaldi Hospital, Naples, Italy
| | - Antonio Cennamo
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, A.O. Dei Colli - Monaldi Hospital, Via Leonardo Bianchi, 80131, Naples, Italy
| | - Fabio Perrotta
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, A.O. Dei Colli - Monaldi Hospital, Via Leonardo Bianchi, 80131, Naples, Italy
| | - Francesco Saverio Cerqua
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, A.O. Dei Colli - Monaldi Hospital, Via Leonardo Bianchi, 80131, Naples, Italy
| | - Raffaele Montesano
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, A.O. Dei Colli - Monaldi Hospital, Via Leonardo Bianchi, 80131, Naples, Italy
| | - Carlo Curcio
- Unit of Thoracic Surgery, A.O. Dei Colli - Monaldi Hospital, Naples, Italy
| | | | | | - Edoardo Grella
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, A.O. Dei Colli - Monaldi Hospital, Via Leonardo Bianchi, 80131, Naples, Italy
| | - Domenico Tafuri
- Department of Sport Sciences and Wellness, University of Naples "Parthenope", Naples, Italy
| | - Gennaro Mazzarella
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, A.O. Dei Colli - Monaldi Hospital, Via Leonardo Bianchi, 80131, Naples, Italy
| | - Andrea Bianco
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Piazza Miraglia, 2, 80138 Naples, Italy Phone:+390815665228, , E-mail:
| |
Collapse
|
6
|
Guarino C, Mazzarella G, De Rosa N, Cesaro C, La Cerra G, Grella E, Perrotta F, Curcio C, Guerra G, Bianco A. Pre-surgical bronchoscopic treatment for typical endobronchial carcinoids. Int J Surg 2016; 33 Suppl 1:S30-5. [DOI: 10.1016/j.ijsu.2016.05.054] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
|
7
|
Perrotta F, Cerqua FS, Cammarata A, Izzo A, Bergaminelli C, Curcio C, Guarino C, Grella E, Forzano I, Cennamo A, Tafuri D, Rocca A, Bianco A, Mazzarella G. Integrated therapeutic approach to giant solitary fibrous tumor of the pleura: report of a case and review of the literature. Open Med (Wars) 2016; 11:220-225. [PMID: 28352798 PMCID: PMC5329829 DOI: 10.1515/med-2016-0042] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2016] [Accepted: 03/07/2015] [Indexed: 11/23/2022] Open
Abstract
The fibrous tumors of the pleura are rare primary tumors, accounting for 5% of malignant pleural neoplasms, which generally originate from sub-mesothelial mesenchymal tissue of the visceral pleura. These tumours generally exhibit clinical benign behavior although 12% of solitary fibrous tumors can be malignant and have worse outcomes. These tumors are considered “giant” when the lesion > 15 cm. Surgical treatment is the best choice for both benign and malignant neoplasms. We retrospectively analyzed the main case series of giant fibrous tumors of the pleura. In addition we report our experience of a 76-year-old woman treated by pre-surgical embolization involving implantation of vascular plugs. Surgery was successfully carried out without complications; imaging and functional assessment 6 months post intervention demonstrated both the absence of recurrence and improvement of lung function parameters.
Collapse
Affiliation(s)
- Fabio Perrotta
- Department of Cardiotho-racic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Naples, Italy
| | - Francesco Saverio Cerqua
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Naples, Italy
| | - Antonino Cammarata
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Naples, Italy
| | - Alessandro Izzo
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Naples, Italy
| | | | - Carlo Curcio
- A.O. dei Colli - Hosp. Monaldi - Thoracic Surgery Unit, Naples, Italy
| | - Carmine Guarino
- A.O. dei Colli - Hosp. Monaldi - Bronchology Unit, Naples, Italy
| | - Edoardo Grella
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Naples, Italy
| | - Imma Forzano
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Naples, Italy
| | - Antonio Cennamo
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Naples, Italy
| | - Domenico Tafuri
- Department of Sport Sciences and Wellness, University of Naples "Parthenope", Naples, Italy
| | - Aldo Rocca
- Department of Medicine and Health Sciences "Vincenzo Tiberio", University of Molise, Campobasso, Italy
| | - Andrea Bianco
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Naples, Italy
| | - Gennaro Mazzarella
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples/Hosp. Monaldi, Naples, Italy
| |
Collapse
|
8
|
Izzo A, Perrotta F, Cennamo A, Cerqua FS, Rinaldi L, Mazzella A, Grella E, Tranfa C, Bianco A, Stefanelli F, Mazzarella G. Spirometry in elderly laryngectomized patients: A feasibility study. Int J Surg 2016; 33 Suppl 1:S4-8. [PMID: 27255127 DOI: 10.1016/j.ijsu.2016.05.058] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
BACKGROUND Laryngeal cancer is the second most common respiratory neoplasm after lung cancer. Laryngectomy is a well established treatment for larynx cancers which involve relevant anatomic alterations. Spirometry is an essential investigation tool for diagnosis and severity of respiratory diseases, difficult to perform in laryngectomees. METHODS 43 consecutive laryngectomized patients were enrolled from July 2014 to March 2015. Patients fulfilling inclusion criteria underwent spirometry at baseline assessment and after two days. During the examination, the spirometer was placed directly on the stoma of the patient, through mouthpiece "Spirometry Filter 74". RESULTS At baseline, 26 eligible laryngectomees correctly performed the spirometry test with mouthpiece adhering to the stoma; 4 patients refused to perform the second spirometry after 2 days. The feasibility of spirometry examination in these patients was 100% despite difficulties in the execution of the test. The Pearson coefficient of reproducibility for FEV1, FVC and Tiffeneau Index was, respectively, 0.98, 0.94 and 0.77. DISCUSSION Spirometry in laryngectomee patients is a feasible procedure for assessment of respiratory function; despite technical difficulties in the execution of the test, our results underline the reproducibility and repeatability of the spirometry. In conclusion, when performed within dedicated respiratory pathophysiology unit, spirometry is a reliable tool in the assessment and follow up of laryngectomees.
Collapse
Affiliation(s)
- Alessandro Izzo
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Dei Colli Hospital, Via Leonardo Bianchi, 80131, Naples, Italy.
| | - Fabio Perrotta
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Dei Colli Hospital, Via Leonardo Bianchi, 80131, Naples, Italy.
| | - Antonio Cennamo
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Dei Colli Hospital, Via Leonardo Bianchi, 80131, Naples, Italy.
| | - Francesco Saverio Cerqua
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Dei Colli Hospital, Via Leonardo Bianchi, 80131, Naples, Italy.
| | - Luca Rinaldi
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Dei Colli Hospital, Via Leonardo Bianchi, 80131, Naples, Italy.
| | - Antonio Mazzella
- Division of Thoracic Surgery, A.O. Dei Colli Monaldi Hospital, Naples, Italy.
| | - Edoardo Grella
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Dei Colli Hospital, Via Leonardo Bianchi, 80131, Naples, Italy.
| | - Carmelindo Tranfa
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Dei Colli Hospital, Via Leonardo Bianchi, 80131, Naples, Italy.
| | - Andrea Bianco
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Dei Colli Hospital, Via Leonardo Bianchi, 80131, Naples, Italy.
| | | | - Gennaro Mazzarella
- Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Dei Colli Hospital, Via Leonardo Bianchi, 80131, Naples, Italy.
| |
Collapse
|
9
|
Masiello R, Iadevaia C, Grella E, Tranfa C, Cerqua F, Rossi G, Santoro G, Amato B, Rocca A, De Dona R, Lavoretano S, Perrotta F. A case of Multiple Unilateral Pulmonary arteriovenous Malformation Relapse: Efficacy of embolization treatment. Open Med (Wars) 2015; 10:513-518. [PMID: 28352746 PMCID: PMC5368875 DOI: 10.1515/med-2015-0087] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2015] [Accepted: 11/04/2015] [Indexed: 01/05/2023] Open
Abstract
Pulmonary arteriovenous Malformations (PAVMs) are a rare vascular alteration characterized by abnormal communications between the pulmonary arteries and veins resulting in an extracardiac right-to-left (R-L) shunt. The majority of PAVMs are associated with an autosomal dominant vascular disorder also known as Osler-Weber-Rendu Syndrome. PAVMs appearance can be both single and multiple. Clinical manifestations include hypoxemia, dyspnea cyanosis, hemoptysis and cerebrovascular ischemic events or abscesses. We report a case of an 18 year old female with severe respiratory failure caused by a relapse of multiple unilateral pulmonary arterovenous fistula. Symptoms at admission include dyspnea, cyanosis and clubbing. The patient underwent pulmonary angio-TC scan, brain CT and echocardiography. The thoracic angio-CT scan showed the presence of PAVMs of RUL and RLL; a marked increase of right bronchial artery caliber and its branches with an aneurismatic dilatation was also observed. The patient underwent percutaneous transcatheter embolization using Amplatzer Vascular Plug IV; a relevant clinical and functional improvement was subsequently recorded. Embolization is effective in the treatment of relapsing PAVMS.
Collapse
Affiliation(s)
- Rossella Masiello
- Department of Cardio-Thoracic and Respiratory Sciences - Second University of Naples - Monaldi Hospital, Naples, Italy
| | - Carlo Iadevaia
- Department of Cardio-Thoracic and Respiratory Sciences - Second University of Naples - Monaldi Hospital, Naples, Italy
| | - Edoardo Grella
- Department of Cardio-Thoracic and Respiratory Sciences - Second University of Naples - Monaldi Hospital, Naples, Italy
| | - Carmelindo Tranfa
- Department of Cardio-Thoracic and Respiratory Sciences - Second University of Naples - Monaldi Hospital, Naples, Italy
| | - Francesco Cerqua
- Department of Cardio-Thoracic and Respiratory Sciences - Second University of Naples - Monaldi Hospital, Naples, Italy
| | - Giovanni Rossi
- U.O.C. Radiology A.O.R.N dei Colli - Monaldi Hospital, Naples, Italy
| | - Giuseppe Santoro
- Department of Cardio-Thoracic and Respiratory Sciences - Second University of Naples - Monaldi Hospital, Naples, Italy
| | - Bruno Amato
- Department of Clinical Medicine and Surgery, University of Naples Federico II, Italy
| | - Aldo Rocca
- Department of Clinical Medicine and Surgery, University of Naples Federico II, Italy
| | - Roberta De Dona
- Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy
| | - Sabrina Lavoretano
- Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy
| | - Fabio Perrotta
- Department of Cardio-Thoracic and Respiratory Sciences - Second University of Naples - Monaldi Hospital, Naples, Italy
| |
Collapse
|
10
|
Nigro E, Imperlini E, Scudiero O, Monaco ML, Polito R, Mazzarella G, Orrù S, Bianco A, Daniele A. Differentially expressed and activated proteins associated with non small cell lung cancer tissues. Respir Res 2015; 16:74. [PMID: 26104294 PMCID: PMC4487583 DOI: 10.1186/s12931-015-0234-2] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2015] [Accepted: 06/09/2015] [Indexed: 12/26/2022] Open
Abstract
Background Lung cancer is a leading cause of mortality. The most common cancer subtype, non small cell lung cancer (NSCLC), accounts for 85-90 % all cases and is mainly caused by environmental and genetic factors. Mechanisms involved in lung carcinogenesis include deregulation of several kinases and molecular pathways affecting cell proliferation, apoptosis and differentiation. Despite advances in lung cancer detection, diagnosis and staging, survival rate still remains poor and novel biomarkers for both diagnosis and therapy need to be identified. In the present study, we have explored the potential of novel specific biomarkers in the diagnosis of NSCLC, and the over-expression/activation of several kinases involved in disease development and progression. Method Lung tumor tissue specimens and adjacent cancer-free tissues from 8 NSCLC patients undergoing surgery were collected. The differential activation status of ERK1/2, AKT and IKBα/NF-κβ was analyzed. Subsequently, protein expression profile of NSCLC vs normal surrounding tissue was compared by a proteomic approach using LC-MS MS. Subsequently, MS/MS outputs were analyzed by the Protein Discoverer platform for label-free quantitation analysis. Finally, results were confirmed by western blotting analysis. Results This study confirms the involvement of ERK1/2, AKT, IKBα and NF-κβ proteins in NSCLC demonstrating a significant over-activation of all tested proteins. Furthermore, we found significant differential expression of 20 proteins (Rsc ≥ 1.50 or ≤ −1.50) of which 7 are under-expressed and 13 over-expressed in NSCLC lung tissues. Finally, we validated, by western blotting, the two most under-expressed NSCLC tissue proteins, carbonic anhydrase I and II isoforms. Conclusion Our data further support the possibility of developing both diagnostic tests and innovative targeted therapy in NSCLC. In addition to selective inhibitors of ERK1/2, AKT, IKBα and NF-κβ, as therapeutic options, our data, for the first time, indicates carbonic anhydrase I and II as attractive targets for development of diagnostic tools enabling selection of patients for a more specific therapy in NSCLC.
Collapse
Affiliation(s)
- E Nigro
- CEINGE-Biotecnologie Avanzate Scarl, Via G. Salvatore 486, 80145, Naples, Italy
| | - E Imperlini
- IRCCS SDN, Via E. Gianturco 113, 80142, Naples, Italy.,Present address: CEINGE-Biotecnologie Avanzate Scarl, Via G. Salvatore 486, 80145, Naples, Italy
| | - O Scudiero
- CEINGE-Biotecnologie Avanzate Scarl, Via G. Salvatore 486, 80145, Naples, Italy.,Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy
| | - M L Monaco
- CEINGE-Biotecnologie Avanzate Scarl, Via G. Salvatore 486, 80145, Naples, Italy
| | - R Polito
- CEINGE-Biotecnologie Avanzate Scarl, Via G. Salvatore 486, 80145, Naples, Italy
| | - G Mazzarella
- Dipartimento di Scienze Cardio-Toraciche e Respiratorie, Seconda Università degli Studi di Napoli, Via L. Bianchi, 80131, Naples, Italy
| | - S Orrù
- CEINGE-Biotecnologie Avanzate Scarl, Via G. Salvatore 486, 80145, Naples, Italy.,Dipartimento di Scienze Motorie e del Benessere, Università di Napoli Parthenope, Via Amm. F. Acton 38, 80133, Naples, Italy
| | - A Bianco
- Cattedra di Malattie dell'Apparato Respiratorio, Dipartimento di Medicina e Scienze per la Salute "V Tiberio", Università del Molise, Via De Sanctis, 86100, Campobasso, Italy
| | - A Daniele
- CEINGE-Biotecnologie Avanzate Scarl, Via G. Salvatore 486, 80145, Naples, Italy. .,Dipartimento di Scienze e Tecnologie Ambientali Biologiche Farmaceutiche, Seconda Università degli Studi di Napoli, Via G. Vivaldi 42, 81100, Caserta, Italy.
| |
Collapse
|
11
|
Significance of Kampo, traditional Japanese medicine, in supportive care of cancer patients. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2013; 2013:746486. [PMID: 23861712 PMCID: PMC3703882 DOI: 10.1155/2013/746486] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/19/2013] [Accepted: 05/28/2013] [Indexed: 02/06/2023]
Abstract
The current standard treatment for cancer is a multidisciplinary therapy whereby various types of treatment are properly combined. Chemotherapy with multiple anticancer drugs is now common, and traditional, complementary, and alternative therapies are adopted as supportive measures. Medical care in Japan is distinguished by the ability for patients to access both Western and Kampo medical cares at the same time. There is a high degree of trust in the safety of Kampo therapies because they are practiced by medical doctors who are educated with fundamental diagnosis of Western medicine. Highly reliable clinical studies are being published, demonstrating that palliative or supportive care for cancer patients using Kampo preparations alleviates adverse effects of chemotherapy or radiotherapy. This paper reports the circumstances around cancer care in Japan where traditional therapeutic Kampo formulas are used for patients undergoing cancer treatment with cutting-edge chemotherapy, specifically to alleviate adverse effects of anticancer drugs.
Collapse
|